跳至主要内容
临床试验/NCT07008274
NCT07008274已完成不适用

Laparoscopic Sleeve Gastrectomy-Induced Decline in Plasma Asprosin and Its Association With Metabolic Recovery

Northern Jiangsu People's Hospital1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2021年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
85
试验地点
1
主要终点
Plasma asprosin levels at 3, 6, and 12 months

研究概览

简要总结

the present study aimed to systematically assess the changes in plasma asprosin levels at 3, 6, and 12 months after LSG, to explore the relationships between asprosin dynamics and key metabolic parameters, including body mass index (BMI), fasting glucose, insulin resistance assessed by the homeostasis model (HOMA-IR), and lipid profiles, and to compare asprosin concentrations between bariatric patients and healthy normal-weight controls.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • age between 18 and 65 years;
  • body mass index (BMI) ≥37.5 kg/m², or BMI ≥32.5 kg/m² with at least one obesity-related comorbidity;
  • availability of complete clinical data and stored plasma samples at preoperative baseline and at 3, 6, and 12 months postoperatively.

排除标准

  • history of prior bariatric or gastrointestinal surgery;
  • active malignancy, chronic inflammatory or infectious disease, or severe hepatic or renal dysfunction;
  • pregnancy during the study period;
  • incomplete clinical or biochemical data.

结局指标

主要结局

Plasma asprosin levels at 3, 6, and 12 months

时间窗: 1 year

次要结局

  • BMI at 3, 6, and 12 months(1 year)

研究者

发起方
Northern Jiangsu People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Daorong Wang

Director

Northern Jiangsu People's Hospital

研究点 (1)

Loading locations...

相似试验